VERO Quote, Financials, Valuation and Earnings

NeuroOne Medical Technologies Corp. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of -88.5%. Venus Concept, Inc.'s return on equity of -1236.95% beat NeuroOne Medical Technologies Corp.'s return on equity of -166.02%.

Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 6004.71%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 239.7%. Given that Venus Concept, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe Venus Concept, Inc. is more attractive than NeuroOne Medical Technologies Corp..

Venus Concept, Inc. has a beta of -0.111, which suggesting that the stock is 111.094% less volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.

Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $1.7M. Venus Concept, Inc.'s net income of -$22.5M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.5M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.04x versus 2.39x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of -321.33%. Venus Concept, Inc.'s return on equity of -1236.95% beat Nutriband, Inc.'s return on equity of -117.44%.

Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 6004.71%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 203.64%. Given that Venus Concept, Inc. has higher upside potential than Nutriband, Inc., analysts believe Venus Concept, Inc. is more attractive than Nutriband, Inc..

Venus Concept, Inc. has a beta of -0.111, which suggesting that the stock is 111.094% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.

Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than Nutriband, Inc. quarterly revenues of $622.5K. Venus Concept, Inc.'s net income of -$22.5M is lower than Nutriband, Inc.'s net income of -$2M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.04x versus 21.33x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical Corp. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of --. Venus Concept, Inc.'s return on equity of -1236.95% beat enVVeno Medical Corp.'s return on equity of -57.7%.

Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 6004.71%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3740.25%. Given that Venus Concept, Inc. has higher upside potential than enVVeno Medical Corp., analysts believe Venus Concept, Inc. is more attractive than enVVeno Medical Corp..

Venus Concept, Inc. has a beta of -0.111, which suggesting that the stock is 111.094% less volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.

Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than enVVeno Medical Corp. quarterly revenues of --. Venus Concept, Inc.'s net income of -$22.5M is lower than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.04x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of -1701.44%. Venus Concept, Inc.'s return on equity of -1236.95% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 6004.71%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 190.97%. Given that Venus Concept, Inc. has higher upside potential than SINTX Technologies, Inc., analysts believe Venus Concept, Inc. is more attractive than SINTX Technologies, Inc..

Venus Concept, Inc. has a beta of -0.111, which suggesting that the stock is 111.094% less volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.

Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Venus Concept, Inc.'s net income of -$22.5M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.04x versus 7.14x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.